
Back in October, GN Hearing had to downgrade its 2021 financial guidance considerably as two key product launches were delayed. Progress is now being made, and Chairman of GN Store Nord Per Wold-Olsen expects the products in question to hit the market in H1 2022, reports the Danish business daily Børsen.
”It is safe to presume that they will be launched during the first half year,” Wold-Olsen tells Børsen, underscoring that the causes behind the delays have been dealt with.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Fruergaard leveraging experience from Danish partnerships in key roles in Brussels
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.